Mer­ck re­jigs ADC deal with Kelun, grab­bing one pro­gram and re­turn­ing an­oth­er

More than two years in­to its part­ner­ship with Chi­na’s Kelun-Biotech, Mer­ck has made fur­ther choic­es on which part of the sprawl­ing ear­ly-stage pipeline it wants …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER